Doong, et al. "Inhibition of the Replication of Hepatitis B Virus In Vitro by 2',3'-Dixeoxy-3'-Thiacytidine and Related Analogues", Proc. Natl. Acad. Sci U.S.A., vol. 88(19), pp. 8495-8499 (1991). |
Jeong, et al. "Structure-Activity Relationships of .beta.-D-(2S,5R)-and .alpha.-D-(2S,5R)-1,3-Oxathiolanyl Nucleosides as Potential Anti-HIV Agents", J. Med. Chem., vol. 36, pp. 2627-2638 (1993). |
Jeong et al., "Asymmetric Synthesis and Biological Evaluation of .beta.-L-(2R,5S)-and .alpha.-L-(2R,5R)-1,3-Oxathiolane-Pyrimidine and -Purine Nucleosides as Potential Anti-HIV Agents", J. Med. Chem., vol. 36(2) pp. 181-195 (1993). |
Frick, et al., "Pharmakokinetics, Oral Bioavailability, and Metabolic Disposition in Rats of (-)-cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl]Cytosine, a Nucleoside Analog Active Against Human Immunodeficiency Virus and Hepatitis B Virus", Antimicrob. Agents & Chemother., vol. 37(11), pp. 2285-2292 (1993). |
Furman, et al., "The Anti-Hepatitis B Virus Activities, Cytotoxicities, and Anabolic Profiles of the (-) and (+) Enantiomers of cis-5-Fluoro-1-[2-(Hydroxymethyl)-1,3-Oxathiolan-5-yl]Cytosine", Antimicrob. Agents & Chemother., vol. 36(12), pp. 2686-2692 (1992). |
Chang et al., J. of Biol. Chemistry, vol. 267, No. 31, pp. 22414-22420, Nov. 5, 1992. |